Search for Regulatory Exclusivity Expiring in 2010

Glossary

Applicant	Tradename	Generic Name	NDA	Approval Date	Type	RLD	Exclusivity Expiration	Patented / Exclusive Use
Shire	LIALDA	mesalamine	022000	Jan 16, 2007	RX	Yes	Jan 16, 2010	NEW PRODUCT
Bayer Hlthcare	YAZ	drospirenone; ethinyl estradiol	021676	Mar 16, 2006	RX	Yes	Jan 26, 2010	TREATMENT OF MODERATE ACNE VULGARIS IN WOMEN AT LEAST 14 YRS OF AGE, WHO HAVE NO KNOWN CONTRAINDICATIONS TO ORAL CONTRACEPTIVE THERAPY, AND HAVE ACHIEVED MENARCHE, IF THE PATIENT DESIRES AN ORAL CONTRACEPTIVE FOR BIRTH CONTROL.
Novartis	FAMVIR	famciclovir	020363	Apr 26, 1996	RX	No	Jan 28, 2010	PEDIATRIC EXCLUSIVITY

20 30 40 50 100

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright © 2000-2010, thinkBiotech LLC.